Literature DB >> 1653120

Differences in beta-adrenergic neuroeffector mechanisms in ischemic versus idiopathic dilated cardiomyopathy.

M R Bristow1, F L Anderson, J D Port, L Skerl, R E Hershberger, P Larrabee, J B O'Connell, D G Renlund, K Volkman, J Murray.   

Abstract

BACKGROUND: We measured the content and activities of components of the beta-adrenergic receptor-G protein-adenylate cyclase complex and adrenergic neurotransmitter levels in left and right ventricular myocardial preparations derived from 77 end-stage failing human hearts from patients with idiopathic dilated cardiomyopathy (IDC) or ischemic dilated cardiomyopathy (ISCDC). METHODS AND
RESULTS: The results were compared with data obtained in 21 nonfailing hearts removed from organ donors. Compared with ISCDC ventricles, IDC left and right ventricles exhibited a greater degree of total beta- or beta 1-receptor downregulation. In contrast, compared with IDC right ventricles, isolated tissue preparations of ISCDC right ventricles exhibited a greater degree of subsensitivity to the inotropic effect of isoproterenol, indicating a relatively greater degree of functional uncoupling of right ventricular ISCDC beta-receptors from mechanical response. In addition, relative to IDC left ventricles, preparations of ISCDC left ventricle exhibited greater subsensitivity to beta-agonist-mediated adenylate cyclase stimulation, indicating functional uncoupling of left ventricular ISCDC beta-receptors from cyclic AMP generation. The uncoupling of beta-receptors in ISCDC left and right ventricles may have been a result of abnormalities in G protein activation of adenylate cyclase; compared with age- and cardiac function-matched respective left or right IDC ventricles, ISCDC left ventricles exhibited less stimulation of adenylate cyclase by NaF or forskolin but no change in Mn2+ stimulation, whereas ISCDC right ventricles exhibited less stimulation by the nonhydrolyzable guanine nucleotide Gpp (NH)p. Also, IDC right ventricles exhibited a "selective" (not present in IDC left ventricles or ISCDC ventricles) decrease in stimulation of adenylate cyclase by Mn2+. Tissue neurotransmitter levels and pertussis toxin-catalyzed ADP ribosylation were altered to similar extents in IDC and ISCDC:
CONCLUSIONS: These data indicate that potentially important differences exist in the regulatory behavior of components of the beta-adrenergic receptor-G protein-adenylate cyclase complex in IDC versus ISCDC, differences that presumably relate to the distinct pathophysiologies of these two types of heart muscle disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1653120     DOI: 10.1161/01.cir.84.3.1024

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  40 in total

Review 1.  MIBG imaging.

Authors:  Amar D Patel; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2002 Jan-Feb       Impact factor: 5.952

2.  Myofibrillar calcium sensitivity of isometric tension is increased in human dilated cardiomyopathies: role of altered beta-adrenergically mediated protein phosphorylation.

Authors:  M R Wolff; S H Buck; S W Stoker; M L Greaser; R M Mentzer
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

3.  Myocardial region (right or left ventricle) and aetiology of heart failure can influence the inotropic effect of ouabain in failing human myocardium.

Authors:  R Padrini; M Panfili; G Magnolfi; D Piovan; D Casarotto; M Ferrari
Journal:  Br J Clin Pharmacol       Date:  1999-11       Impact factor: 4.335

Review 4.  Alterations in adrenergic receptor signaling in heart failure.

Authors:  S Lamba; W T Abraham
Journal:  Heart Fail Rev       Date:  2000-03       Impact factor: 4.214

5.  Carvedilol tratment of chronic heart failure: a new era.

Authors:  M Bristow
Journal:  Heart       Date:  1998-06       Impact factor: 5.994

6.  Effects of propranolol treatment on left ventricular function and intracellular calcium regulation in rats with postinfarction heart failure.

Authors:  S E Litwin; S E Katz; J P Morgan; P S Douglas
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

Review 7.  Adrenergic and muscarinic receptor regulation and therapeutic implications in heart failure.

Authors:  W Schmitz; P Boknik; B Linck; F U Müller
Journal:  Mol Cell Biochem       Date:  1996 Apr 12-26       Impact factor: 3.396

Review 8.  Beta blockers in heart failure haemodynamics, clinical effects and modes of action.

Authors:  P A R de Milliano; J G P Tijssen; P A van Zwieten; K I Lie
Journal:  Neth Heart J       Date:  2001-11       Impact factor: 2.380

9.  Evaluation of the regional responsivity to ryanodine of human myocardium from patients with idiopathic dilated cardiomyopathy and secondary cardiomyopathies.

Authors:  R Padrini; M Panfili; L Testolin; F Pesarin; D Piovan; G Magnolfi; U Livi; D Casarotto; S Dalla Volta
Journal:  Basic Res Cardiol       Date:  1996 Sep-Oct       Impact factor: 17.165

10.  Effects of carvedilol on adrenergic receptor pharmacology in human ventricular myocardium and lymphocytes.

Authors:  M R Bristow; P Larrabee; B Müller-Beckmann; W Minobe; R Roden; L Skerl; J Klein; D Handwerger; J D Port
Journal:  Clin Investig       Date:  1992
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.